About Imbio
Imbio, now a part of 4DMedical following its acquisition in December 2023, is a leading healthcare AI company specializing in advanced medical imaging analysis. The company’s solutions are designed to transform standard medical images, such as CT, MR, and X-ray scans, into rich visual maps and comprehensive quantitative reports. This technology empowers physicians with detailed, data-driven insights into a patient’s condition, enabling more precise diagnosis, personalized treatment planning, and effective therapy tracking for a range of acute and chronic cardiothoracic diseases.
For physicians, Imbio’s AI-powered algorithms offer fully automated 3D visualization and quantitative analysis, integrating seamlessly into existing clinical workflows. Their product suite addresses critical areas such as Lung Density Analysis (for emphysema and COPD), Lung Texture Analysis (for interstitial lung abnormalities), Pulmonary Hypertension Assessment, Airway Analysis, and Coronary Calcification. These tools aid in early disease detection, accurate disease staging, patient selection for interventions, and monitoring treatment response, ultimately enhancing diagnostic power and supporting improved patient outcomes.
The company’s commitment to physician-centric design ensures that its AI solutions are clinically relevant and easy to adopt, helping to bridge the gap between the vast information contained in medical images and the demands of modern healthcare. Imbio’s technology is utilized globally by radiologists, pulmonologists, and other specialists, and also supports medical device and pharmaceutical companies in clinical trials and drug development.
Focus Areas
Business Intelligence
| Key Investors | Invenshure, HHS (Department of Health and Human Services), Angel Investors |
| Partnerships | 4DMedical (acquired Imbio), Blackford Analysis, MEDICAL-NOTE, Olympus Medical, 3DR Labs (Accumen Company), Aidoc, Siemens Healthineers, Genentech, Nuance AI Marketplace, Heart&Lung Health Ltd, Spesana, Flywheel, Wellbeing, TeraRecon, NTT DATA Services, GE Healthcare |
| Acquisitions | Acquired by 4DMedical on December 11, 2023, for an upfront purchase price of $25M. |
| Technology | Cloud-native (AWS), on-premise (VMware), web-based application, dockerized algorithms, machine learning, deep learning, automated workflows, 3D visualization, quantitative reporting, automated de-identification/re-identification, encrypted transmission |
| FDA Clearances | 3 cleared products (estimated) |
What Physicians Need to Know
Imbio's solutions are designed to be fully automated, integrating seamlessly into existing workflows without requiring additional steps from physicians. This allows for rapid, quantitative analysis and 3D visualization of medical images, providing objective data that enhances diagnostic confidence, aids in disease staging, and supports personalized treatment decisions. The ability to quickly visualize and quantify abnormalities helps in early disease detection, monitoring treatment response, and improving overall patient care efficiency. Furthermore, Imbio's patient-centered reports, like the LungMapu2122, can facilitate patient education and counseling, particularly for initiatives like smoking cessation.
Imbio offers flexible deployment options, including Imbio Cloud (AWS-based) or Imbio Enterprise (on-premise VMware) platforms. Their dockerized algorithms can also be delivered through various partner platforms. Imbio integrates with major radiology reporting systems and AI marketplaces, such as Nuance AI Marketplace (PowerScribe), Siemens syngo.via, GE Health Cloud, Blackford Platform, Aidoc, TeraRecon, and FerrumHealth, ensuring that analysis outputs (3D DICOM series and quantitative reports) are automatically sent to PACS and available within existing clinical environments.
Reviews & Opinions
Videos
News, demos, and interviews about Imbio.
Videos load interactively. If none appear, search YouTube for Imbio →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]